Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127260921 | 12726092 | 1 | I | 20160831 | 20160908 | 20160908 | EXP | GB-MHRA-MIDB-1B4615F1-96CE-495C-B1BC-CEE4C04C804B | GB-MYLANLABS-2016M1037478 | MYLAN | 0.00 | Y | 0.00000 | 20160908 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127260921 | 12726092 | 1 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 20 MG, QD (MORNING) | Y | U | 0 | 20 | MG | QD | ||||||
| 127260921 | 12726092 | 2 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | UNK | Y | U | 90763 | |||||||||
| 127260921 | 12726092 | 3 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 75 MG, QD (MORNING) | U | 0 | 75 | MG | QD | |||||||
| 127260921 | 12726092 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | 40 MG, QD (NIGHT.) | U | 0 | 40 | MG | QD | |||||||
| 127260921 | 12726092 | 5 | C | BECLOMETASONE | BECLOMETHASONE DIPROPIONATE | 1 | Respiratory (inhalation) | 100 ?G, BID | U | 0 | 100 | UG | BID | ||||||
| 127260921 | 12726092 | 6 | C | BISOPROLOL | BISOPROLOL | 1 | 3.75 MG, QD (MORNING.) | U | 0 | 3.75 | MG | QD | |||||||
| 127260921 | 12726092 | 7 | C | CANDESARTAN | CANDESARTAN | 1 | 8 MG, QD (MORNING.) | U | 0 | 8 | MG | QD | |||||||
| 127260921 | 12726092 | 8 | C | CODEINE | CODEINE | 1 | 30 MG, UNK (4 TIMES A DAY) | U | 0 | 30 | MG | ||||||||
| 127260921 | 12726092 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 40 MG, QD (MORNING. CHANGED TO LANSOPRAZOLE ON ADMISSION.) | U | 0 | 40 | MG | QD | |||||||
| 127260921 | 12726092 | 10 | C | QUININE SULFATE. | QUININE SULFATE | 1 | 300 MG, QD (NIGHT) | U | 0 | 300 | MG | QD | |||||||
| 127260921 | 12726092 | 11 | C | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | 200 ?G, UNK | U | 0 | 200 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127260921 | 12726092 | 8 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127260921 | 12726092 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127260921 | 12726092 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |